These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hepatitis C and B virus in schistosomiasis patients on oral or parenteral treatment. El-Sabah AA; El-Metwally MT; Abozinadah NY J Egypt Soc Parasitol; 2011 Aug; 41(2):307-14. PubMed ID: 21980769 [TBL] [Abstract][Full Text] [Related]
5. [Advances in research on antischistosomal drugs]. Qiu SJ; Xia CM Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510 [TBL] [Abstract][Full Text] [Related]
6. [Advanced schistosomiasis chemotherapy and assistance in Xinjian County, 2005-2009]. Mao YH; Hu WC; Tu J; Chen FJ; Wan RF; Ning A; Zhang B; Chen Z; Li M; Zhang BY; Zou JX; Deng Q Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Apr; 24(2):203-4, 211. PubMed ID: 22799170 [TBL] [Abstract][Full Text] [Related]
7. Preliminary report on long term cure of schistosomiasis using metrifonate (Bilarcil/Dipterex)--a new antischistosomal drug. Onadeko MO West Afr J Pharmacol Drug Res; 1979; 5(1):19-24. PubMed ID: 122130 [TBL] [Abstract][Full Text] [Related]
8. Clinical study on cerebral schistosomiasis japonica on Leyte Island, Philippines: follow-up study 6 years after treatment with antischistosomal drugs. Hayashi M; Matsuda H; Tormis LC; Nosenas JS; Blas BL Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):502-6. PubMed ID: 6100141 [No Abstract] [Full Text] [Related]
9. Schistosomiasis: recent developments in immunology and treatment. Martin DW; Naughton JL; Smith LH West J Med; 1980 Jul; 133(1):49-56. PubMed ID: 7222647 [No Abstract] [Full Text] [Related]
10. Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads. Panic G; Keiser J Curr Opin Pharmacol; 2018 Oct; 42():27-33. PubMed ID: 30077117 [TBL] [Abstract][Full Text] [Related]
11. "Control of schistosomiasis": morbidity-reduction and chemotherapy. Mott KE Acta Leiden; 1982; 49():101-111. PubMed ID: 7188153 [No Abstract] [Full Text] [Related]
12. Long-term toxicity of antischistosomal drugs: summary and perspectives. J Toxicol Environ Health; 1975 Nov; 1(2):335-51. PubMed ID: 1206776 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of the activity of current antischistosomal agents and their use in children]. Bougnoux ME; Chaplain C; Houin R Ann Pediatr (Paris); 1987 May; 34(5):397-402. PubMed ID: 3619308 [No Abstract] [Full Text] [Related]
14. Experimental chemotherapy of schistosomiasis. VI. Egg suppressive activity of thiosinamine. Pellegrino J; Machado A Rev Bras Pesqui Med Biol; 1972; 5(1-2):43-5. PubMed ID: 4680453 [No Abstract] [Full Text] [Related]
15. Current chemotherapy of schistosomiasis japonica in the Philippines. Santos AT Southeast Asian J Trop Med Public Health; 1976 Jun; 7(2):306-9. PubMed ID: 193200 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic evaluation of hycanthone in school children in rural endemic area in Egypt. Mousa AH; El-Abdin AZ; El-Garem AA; El-Raziky EH; Fadl AA Egypt J Bilharz; 1974; 1(1):65-83. PubMed ID: 4469236 [No Abstract] [Full Text] [Related]
17. [Experiences with large scale chemotherapy in the control of schistosomiasis in Brazil]. Katz N Rev Inst Med Trop Sao Paulo; 1980; 22(1):40-51. PubMed ID: 7433820 [No Abstract] [Full Text] [Related]
18. Modern trends in the management of hepato-splenic schistosomiasis. Mousa AH Egypt J Bilharz; 1978; 4(1):1-8. PubMed ID: 648456 [No Abstract] [Full Text] [Related]
19. The rational use of antischistosomal drugs in schistosomiasis control. Chandiwana SK; Taylor P Soc Sci Med; 1990; 30(10):1131-8. PubMed ID: 2194295 [TBL] [Abstract][Full Text] [Related]
20. Effect of treatment with different antibilharzial drugs on renal functions in urinary schistosomiasis. el-Zayadi AM; Shoeb SM; Sabour MS; Basmy K Tropenmed Parasitol; 1974 Jun; 25(2):147-52. PubMed ID: 4418544 [No Abstract] [Full Text] [Related] [Next] [New Search]